✦ LIBER ✦

Huntington's disease: from molecular pathogenesis to clinical treatment

✍ Scribed by Christopher A Ross; Sarah J Tabrizi

Book ID: 114409639
Publisher: The Lancet
Year: 2011
Tongue: English
Weight: 915 KB
Volume: 10
Category: Article
ISSN: 1474-4465
DOI: 10.1016/s1474-4422(10)70245-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Huntington's disease-like 2: a clinical,

Huntington's disease-like 2: a clinical, pathological, and molecular comparison to Huntington's disease

✍ Russell L Margolis; Susan E Holmes 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 465 KB

Huntington's Disease: New Paths to Patho

Huntington's Disease: New Paths to Pathogenesis

✍ Christopher A Ross 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 191 KB

Huntingtin and the molecular pathogenesi

Huntingtin and the molecular pathogenesis of Huntington's disease

✍ Landles, Christian; Bates, Gillian P. 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB

Marfan syndrome: from molecular pathogen

Marfan syndrome: from molecular pathogenesis to clinical treatment

✍ Francesco Ramirez; Harry C Dietz 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 377 KB

Huntington's disease: From molecular bas

Huntington's disease: From molecular basis to therapeutic advances

✍ Sylvia Krobitsch; Aleksey G. Kazantsev 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 591 KB

Twelfth annual symposia on etiology, pat

Twelfth annual symposia on etiology, pathogenesis, and treatment of parkinson's disease and etiology, pathogenesis, and treatment of Huntington's disease

📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

The morning session will focus on Neuroprotection in Parkinson's Disease: Design, Implementation and Interpretation of Clinical and Functional Neuroimaging Studies. There will be three lectures by the following individuals with allotted time for questions and answers after each presenter. After the